Parimifasor

CAS No. 1796641-10-5

Parimifasor ( LYC-30937-EC;LYC30937 )

Catalog No. M12714 CAS No. 1796641-10-5

Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 In Stock
5MG 87 In Stock
10MG 132 In Stock
25MG 267 In Stock
50MG 394 In Stock
100MG 582 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Parimifasor
  • Note
    Research use only, not for human use.
  • Brief Description
    Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
  • Description
    Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).Psoriasis Phase 2 Clinical
  • Synonyms
    LYC-30937-EC;LYC30937
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    Psoriasis

Chemical Information

  • CAS Number
    1796641-10-5
  • Formula Weight
    460.21
  • Molecular Formula
    C18H11Cl2F4N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥150 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    O=C(/N=C(NC1=CC(F)=CC(Cl)=C1)\NC2=NNC(C(F)(F)F)=C2)C3=CC=CC(Cl)=C3
  • Chemical Name
    3-chloro-N-[(3-chloro-5-fluoroanilino){[5-(trifluoromethyl)-1H-pyrazol-3-yl]amino}methylidene]benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Aka Lumine

    AkaLumine is a luciferin analogue.

  • Methyl 3-methoxyacry...

    Methyl 3-methoxyacrylate is a natural product for research related to life sciences.

  • Epoxomicin

    Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome.